Western Europe remains at the forefront of evidence-based harm reduction and treatment interventions. The majority of the countries in the region have adopted a health-based strategy towards drug use (including decriminalisation of possession for personal use), and are moving towards more proportionate sentences for drug offences.
This report addresses the use of methamphetamine (crystal meth or tina) and slamming (intravenous use) as a route of administration, by men who have sex with men (MSM), in a sexual setting - also known as chemsex.
This conference aims at understanding the alternative and sustainable use of cannabis variations as industrial hemp and as a medicine. The guest speakers will highlight that cannabis can be a boost for growth and employment in the European Union.
Danish MPs today debated a bill which would allow people to bring a friend with them into the drug consumption room, to assist them with injecting. We interviewed Nanna W. Gotfredsen, head of Gadejuristen (Danish Street Lawyers) about the significance of this reform.
Harm Reduction International published a report and a monitoring tool on harm reduction in prison, both of which are part of the European Union co-funded project “Improving Prison Conditions by Strengthening Infectious Disease Monitoring”.
One in five “legal highs” sent for testing in Wales last year were found to contain illegal substances, has revealed the new report from the Welsh Emerging Drugs and Identification of Novel Substances Project (WEDINOS).
This second annual report from the Welsh Emerging Drugs & Identification of Novel Substances Project (WEDINOS) focuses on new psychoactive substances (NPS) but also in the harms experienced by those using them.
The article discusses why a disproportionate number of young black people is convicted for drug offences in London, shedding light on the main underlying causes: social exclusion, biased policing, gang culture and links to the cocaine trade.
Following the success of the European Initiative Hepatitis C and Drug Use’s journal supplement “Viral Hepatitis and Drug Use in Europe", the Correlation Network is seeking original research articles on biomedical and public health aspects of HCV and drug use in Europe for publication.
The EMCDDA offers an overview on naloxone access in the European Union and summarises the effectiveness of hand-out naloxone programmes to save the lives of people at risk of overdosing as well as giving recommendations for the future.
At the reconvened 58th CND in Vienna, a number of side events were held on 9th December 2015, including 'Public health as a basis for drug policy in Portugal'. Portuguese government officials spoke at the event, alongside Wolfgang Gotz, Director of European Monitoring Centre on Drugs and Drug…